DK1353688T3 - Fremgangsmåde og sammensætninger til immunisering med Psedomonas V-antigenet - Google Patents

Fremgangsmåde og sammensætninger til immunisering med Psedomonas V-antigenet

Info

Publication number
DK1353688T3
DK1353688T3 DK02706015T DK02706015T DK1353688T3 DK 1353688 T3 DK1353688 T3 DK 1353688T3 DK 02706015 T DK02706015 T DK 02706015T DK 02706015 T DK02706015 T DK 02706015T DK 1353688 T3 DK1353688 T3 DK 1353688T3
Authority
DK
Denmark
Prior art keywords
antigen
psedomonas
immunization
compositions
methods
Prior art date
Application number
DK02706015T
Other languages
Danish (da)
English (en)
Inventor
Dara W Frank
Jeannine Wiener-Kronish
Timothy L Yahr
Teiji Sawa
Robert B Fritz
Original Assignee
Mcw Res Found Inc
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/770,916 external-priority patent/US6827935B2/en
Application filed by Mcw Res Found Inc, Univ California filed Critical Mcw Res Found Inc
Application granted granted Critical
Publication of DK1353688T3 publication Critical patent/DK1353688T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/567—Framework region [FR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/21—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pseudomonadaceae (F)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
DK02706015T 2001-01-26 2002-01-25 Fremgangsmåde og sammensætninger til immunisering med Psedomonas V-antigenet DK1353688T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/770,916 US6827935B2 (en) 1998-11-25 2001-01-26 Method of and compositions for immunization with the pseudomonas V antigen
US26479501P 2001-01-29 2001-01-29
PCT/US2002/002382 WO2002064161A2 (en) 2001-01-26 2002-01-25 Method and compositions for immunization with the pseudomonas v antigen

Publications (1)

Publication Number Publication Date
DK1353688T3 true DK1353688T3 (da) 2007-04-10

Family

ID=26950766

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02706015T DK1353688T3 (da) 2001-01-26 2002-01-25 Fremgangsmåde og sammensætninger til immunisering med Psedomonas V-antigenet

Country Status (8)

Country Link
US (2) US7494653B2 (de)
EP (1) EP1353688B1 (de)
JP (1) JP4355786B2 (de)
AT (1) ATE347374T1 (de)
DE (1) DE60216564T2 (de)
DK (1) DK1353688T3 (de)
ES (1) ES2275840T3 (de)
WO (1) WO2002064161A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2466474C (en) * 2001-11-13 2012-10-09 Shire Biochem Inc. Compositions comprising spa-1, spa-2 and spa-3, polypeptides and related uses
EP1790659B1 (de) * 2001-11-13 2013-07-31 ID Biomedical Corporation Pseudomonas aeruginosa Polypeptide
US7981601B2 (en) 2003-08-01 2011-07-19 Institute Of Basic Medical Sciences Method of preparing polyepitope chimeric gene vaccine
US20090208535A1 (en) * 2004-06-28 2009-08-20 Proteome Systems Intellectual Property Pty Ltd Novel Methods of Diagnosis of Treatment of P. Aeruginosa Infection and Reagents Therefor
CA2706732A1 (en) 2007-11-30 2009-06-11 Kalobios Pharmaceuticals, Inc. Antibodies to the pcrv antigen of pseudomonas aeruginosa
BRPI0906810A2 (pt) 2008-01-10 2019-10-01 Shionogi & Co anticorpo contra pcrv
CA2751433A1 (en) * 2009-02-04 2010-08-12 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
PL2407537T6 (pl) 2009-03-11 2016-07-29 Shionogi & Co Humanizowane przeciwciało PcrV wykazujące aktywność przeciwko Pseudomonas
RS60920B1 (sr) 2011-11-07 2020-11-30 Medimmune Ltd Kombinovane terapije primenom anti-pseudomonas psl i pcrv vezujućih molekula
CA2863468A1 (en) * 2012-03-02 2013-09-06 Ablynx Nv Pseudomonas aeruginosa pcrv binding single variable domain antibodies
KR20200041311A (ko) 2017-06-23 2020-04-21 노소코미얼 백신 코포레이션 면역원성 조성물
US20200283829A1 (en) * 2017-09-29 2020-09-10 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the risk of developing pulmonary colonization/infection by pseudomonas aeruginosa
WO2020252029A1 (en) 2019-06-11 2020-12-17 Regeneron Pharmaceuticals, Inc. Anti-pcrv antibodies that bind pcrv, compositions comprising anti-pcrv antibodies, and methods of use thereof
FR3114970B1 (fr) * 2020-10-08 2023-06-30 Univ Tours Combinaison d’anticorps inhalés avec des agents immunomodulateurs pour le traitement ou la prévention d’inféctions respiratoires

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599665A (en) 1993-12-21 1997-02-04 Mcw Research Foundation Pseudomonas aeruginosa nucleic acids encoding exoenzyme S activity and use thereof in detecting pseudomonas aeruginosa infection
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
EP1049488B1 (de) 1998-11-25 2006-03-01 MCW Research Foundation, Inc. Verfahren und zusammensetzungen für impfung mit dem pseudomonas aeruginosa v-antigen

Also Published As

Publication number Publication date
ES2275840T3 (es) 2007-06-16
JP4355786B2 (ja) 2009-11-04
DE60216564D1 (de) 2007-01-18
US8101347B2 (en) 2012-01-24
US7494653B2 (en) 2009-02-24
EP1353688A2 (de) 2003-10-22
ATE347374T1 (de) 2006-12-15
US20050063985A1 (en) 2005-03-24
DE60216564T2 (de) 2007-10-11
WO2002064161A9 (en) 2002-10-31
WO2002064161A3 (en) 2002-12-12
JP2005500250A (ja) 2005-01-06
WO2002064161A2 (en) 2002-08-22
US20090191241A1 (en) 2009-07-30
EP1353688B1 (de) 2006-12-06

Similar Documents

Publication Publication Date Title
DK1049488T3 (da) Fremgangsmåde og præparat til immunisering med Pseudomonas aeruginosa-V-antigenet
DK1353688T3 (da) Fremgangsmåde og sammensætninger til immunisering med Psedomonas V-antigenet
AU2001261741A1 (en) Diagnosis, prevention and treatment of crohn's disease using the ompc antigen
DK0865297T3 (da) Vaccinesammensætninger til intranasal administration omfattende chitosan og anvendelsen deraf
DE122010000042I1 (de) Solubilisierung von capsulären Polysacchariden
DE60118166D1 (de) Ohrenstoepsel
DK1535068T3 (da) Anordninger og fremgangsmåder til detektering af fostervand i vaginalsekreter
DK2133100T3 (da) MTB32A-Antigen af Mycobacterium tuberculosis med inaktiveret aktivt sted og fusionsproteiner deraf
HUP0303655A2 (hu) Proliferatív ileitis elleni hatékonyabb vakcinák, előállításuk és alkalmazásuk
UA92721C2 (ru) Обогащенная популяция антител, высокоспецифических к антигену поверхностного полисахарида липоарабиноманана (lam) микобактерии, способ выявления микобактериальной инфекции в образце и набор для выявления микобактериальной инфекции
DK1395283T3 (da) Heterolog beskyttelse induceret ved immunisering med Invaplex-vaccine
AP2001002073A0 (en) Neutralizing antibody and immunomodulatory enhancing compositions
AU3439799A (en) Immunization against and treatment for infection by (h.pylori)
DE60220642D1 (de) Perylenequinone zur anwendung mit immunotherapeutischen mitteln
WO2003006055A8 (en) Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit
EP0836480A4 (de) Zusammensetzungen, welche adp-ribosyltransferase-aktivität ausweisen und methoden für ihre herstellung und die verwendung derselben
DE69615537T2 (de) Helicobacter pylori antigen
DE60229624D1 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion
ATE375170T1 (de) Adjuvanskombinationen zur immunisierung und vakzine
WO2002030321A3 (en) Bird diagnostics and treatments
UA4478U (uk) Спосіб діагностики ефективності фототерапії